Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells

Alfredo Budillon, Pierosandro Tagliaferri, Michele Caraglia, Maria Rosaria Torrisi, Nicola Normanno, Stefano Iacobelli, Giovannella Palmieri, Maria Patrizia Stoppelli, Luigi Frati, Angelo Raffaele Bianco

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Unregulated or increased expression of epidermal growth factor receptor (EGF-R) is a common event in neoplastic transformation; modulation of such a receptor by physiological agents could be, therefore, of clinical interest. We have studied the binding ability, the availability at cell surface, and the synthesis of EGF-R in the A431 and KB human epidermoid cancer cell lines after treatment with recombinant α-interferon (IFN-α). After 48 h of treatment, IFN-α induces, in both cell lines, growth inhibition and enhances class I major histocompatibility HLA complex expression, which is a common marker of IFN action. [125I]EGF total binding assessed after 48 h of treatment with IFN-α shows a dose-dependent upregulation of EGF-R binding capacity. Saturation plots of the binding data show that IFN-α treatment does not dramatically alter the affinity of the EGF-R and indicate that IFN-α only increases the number of low affinity receptors. We show that this effect is due to a specific increase in the synthesis of the receptor protein, as assessed by immunoprecipitation of [35S]methionine-labeled cell extracts. Electron microscopy analysis has confirmed an increase of EGF-R proteins at cell surface without major changes in the morphology of the cells. Taken together, these results indicate that IFN-α consistently induces both the binding capacity and the synthesis of EGF-R in human epidermoid cancer cells and suggest the use of such a mechanism for new anticancer therapies.

Original languageEnglish
Pages (from-to)1294-1299
Number of pages6
JournalCancer Research
Volume51
Issue number4
Publication statusPublished - Feb 15 1991

Fingerprint

Epidermal Growth Factor Receptor
Interferons
Up-Regulation
Neoplasms
Cell Line
Cell Extracts
Major Histocompatibility Complex
Immunoprecipitation
Epidermal Growth Factor
Methionine
Electron Microscopy
Membrane Proteins
Growth
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Budillon, A., Tagliaferri, P., Caraglia, M., Torrisi, M. R., Normanno, N., Iacobelli, S., ... Bianco, A. R. (1991). Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells. Cancer Research, 51(4), 1294-1299.

Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells. / Budillon, Alfredo; Tagliaferri, Pierosandro; Caraglia, Michele; Torrisi, Maria Rosaria; Normanno, Nicola; Iacobelli, Stefano; Palmieri, Giovannella; Stoppelli, Maria Patrizia; Frati, Luigi; Bianco, Angelo Raffaele.

In: Cancer Research, Vol. 51, No. 4, 15.02.1991, p. 1294-1299.

Research output: Contribution to journalArticle

Budillon, A, Tagliaferri, P, Caraglia, M, Torrisi, MR, Normanno, N, Iacobelli, S, Palmieri, G, Stoppelli, MP, Frati, L & Bianco, AR 1991, 'Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells', Cancer Research, vol. 51, no. 4, pp. 1294-1299.
Budillon, Alfredo ; Tagliaferri, Pierosandro ; Caraglia, Michele ; Torrisi, Maria Rosaria ; Normanno, Nicola ; Iacobelli, Stefano ; Palmieri, Giovannella ; Stoppelli, Maria Patrizia ; Frati, Luigi ; Bianco, Angelo Raffaele. / Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells. In: Cancer Research. 1991 ; Vol. 51, No. 4. pp. 1294-1299.
@article{5c50de57b7104245a49e514683b7aba4,
title = "Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells",
abstract = "Unregulated or increased expression of epidermal growth factor receptor (EGF-R) is a common event in neoplastic transformation; modulation of such a receptor by physiological agents could be, therefore, of clinical interest. We have studied the binding ability, the availability at cell surface, and the synthesis of EGF-R in the A431 and KB human epidermoid cancer cell lines after treatment with recombinant α-interferon (IFN-α). After 48 h of treatment, IFN-α induces, in both cell lines, growth inhibition and enhances class I major histocompatibility HLA complex expression, which is a common marker of IFN action. [125I]EGF total binding assessed after 48 h of treatment with IFN-α shows a dose-dependent upregulation of EGF-R binding capacity. Saturation plots of the binding data show that IFN-α treatment does not dramatically alter the affinity of the EGF-R and indicate that IFN-α only increases the number of low affinity receptors. We show that this effect is due to a specific increase in the synthesis of the receptor protein, as assessed by immunoprecipitation of [35S]methionine-labeled cell extracts. Electron microscopy analysis has confirmed an increase of EGF-R proteins at cell surface without major changes in the morphology of the cells. Taken together, these results indicate that IFN-α consistently induces both the binding capacity and the synthesis of EGF-R in human epidermoid cancer cells and suggest the use of such a mechanism for new anticancer therapies.",
author = "Alfredo Budillon and Pierosandro Tagliaferri and Michele Caraglia and Torrisi, {Maria Rosaria} and Nicola Normanno and Stefano Iacobelli and Giovannella Palmieri and Stoppelli, {Maria Patrizia} and Luigi Frati and Bianco, {Angelo Raffaele}",
year = "1991",
month = "2",
day = "15",
language = "English",
volume = "51",
pages = "1294--1299",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells

AU - Budillon, Alfredo

AU - Tagliaferri, Pierosandro

AU - Caraglia, Michele

AU - Torrisi, Maria Rosaria

AU - Normanno, Nicola

AU - Iacobelli, Stefano

AU - Palmieri, Giovannella

AU - Stoppelli, Maria Patrizia

AU - Frati, Luigi

AU - Bianco, Angelo Raffaele

PY - 1991/2/15

Y1 - 1991/2/15

N2 - Unregulated or increased expression of epidermal growth factor receptor (EGF-R) is a common event in neoplastic transformation; modulation of such a receptor by physiological agents could be, therefore, of clinical interest. We have studied the binding ability, the availability at cell surface, and the synthesis of EGF-R in the A431 and KB human epidermoid cancer cell lines after treatment with recombinant α-interferon (IFN-α). After 48 h of treatment, IFN-α induces, in both cell lines, growth inhibition and enhances class I major histocompatibility HLA complex expression, which is a common marker of IFN action. [125I]EGF total binding assessed after 48 h of treatment with IFN-α shows a dose-dependent upregulation of EGF-R binding capacity. Saturation plots of the binding data show that IFN-α treatment does not dramatically alter the affinity of the EGF-R and indicate that IFN-α only increases the number of low affinity receptors. We show that this effect is due to a specific increase in the synthesis of the receptor protein, as assessed by immunoprecipitation of [35S]methionine-labeled cell extracts. Electron microscopy analysis has confirmed an increase of EGF-R proteins at cell surface without major changes in the morphology of the cells. Taken together, these results indicate that IFN-α consistently induces both the binding capacity and the synthesis of EGF-R in human epidermoid cancer cells and suggest the use of such a mechanism for new anticancer therapies.

AB - Unregulated or increased expression of epidermal growth factor receptor (EGF-R) is a common event in neoplastic transformation; modulation of such a receptor by physiological agents could be, therefore, of clinical interest. We have studied the binding ability, the availability at cell surface, and the synthesis of EGF-R in the A431 and KB human epidermoid cancer cell lines after treatment with recombinant α-interferon (IFN-α). After 48 h of treatment, IFN-α induces, in both cell lines, growth inhibition and enhances class I major histocompatibility HLA complex expression, which is a common marker of IFN action. [125I]EGF total binding assessed after 48 h of treatment with IFN-α shows a dose-dependent upregulation of EGF-R binding capacity. Saturation plots of the binding data show that IFN-α treatment does not dramatically alter the affinity of the EGF-R and indicate that IFN-α only increases the number of low affinity receptors. We show that this effect is due to a specific increase in the synthesis of the receptor protein, as assessed by immunoprecipitation of [35S]methionine-labeled cell extracts. Electron microscopy analysis has confirmed an increase of EGF-R proteins at cell surface without major changes in the morphology of the cells. Taken together, these results indicate that IFN-α consistently induces both the binding capacity and the synthesis of EGF-R in human epidermoid cancer cells and suggest the use of such a mechanism for new anticancer therapies.

UR - http://www.scopus.com/inward/record.url?scp=0025802968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025802968&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 1294

EP - 1299

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 4

ER -